Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Penicillin Allergy Delabeling After a One-Dose Versus Two-Dose Graded Direct Oral Challenge

NCT06303128 is registered in ClinicalTrials.gov with James Tarbox, MD as lead sponsor.

NCT NCT06303128
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06303128 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Penicillin Allergy Delabeling After a One-Dose Versus Two-Dose Graded Direct Oral Challenge
Lead sponsor
James Tarbox, MD
Phase
Phase 3
Overall status
Recruiting
Start date
February 3, 2024
Completion date
December 31, 2026
Enrollment
380 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

penicillin allergy